Common UMOD genetic variants drive uromodulin overproduction and increased CKD risk.

The evidence from large-scale genomic studies and functional research confirms that genetic variations in the UMOD gene are primary drivers of uromodulin dysregulation and long-term decline in kidney function.

Clinical effectiveness and population data

Large-scale meta-analyses, including data from the CKDGen Consortium involving over 60,000 to 100,000 individuals, consistently identify common variants in the UMOD promoter (specifically rs12917707) as major risk factors for chronic kidney disease (CKD).

• eGFR and CKD Risk: Carriers of the risk-associated major allele (T or G, depending on the strand) show a significant reduction in estimated glomerular filtration rate (eGFR). The odds ratio (OR) for developing CKD per risk allele is approximately 1.13 to 1.25, with a corresponding decrease in eGFR (beta values ranging from -0.010 to -0.065).
• Disease Progression: Beyond initial susceptibility, these variants are associated with a steeper annual decline in eGFR and an increased risk of progressing to end-stage renal disease (ESRD). Mendelian randomization studies further support a causal link, with an OR of 1.30 for CKD per standard deviation increase in uromodulin levels.

Mechanistic explanations

The pathogenicity of UMOD variants stems from their role as expression quantitative trait loci (eQTLs) that alter the production of uromodulin in the thick ascending limb (TAL) of the loop of Henle.

• Overexpression and Secretion: Common promoter variants increase transcriptional activity, leading to significantly higher urinary uromodulin concentrations (e.g., geometric means of 14.05 mg/L in risk carriers vs. 10.24 mg/L in non-carriers).
• Pathological Pathways: Elevated uromodulin levels trigger chronic tubulointerstitial injury. Mechanistic models suggest this occurs via:
  • ER Stress and Inflammation: High production rates can induce endoplasmic reticulum (ER) stress and activate the NLRP3 inflammasome, promoting interstitial inflammation.
  • Sodium Regulation: Uromodulin upregulates the sodium-potassium-chloride cotransporter (NKCC2), which increases salt reabsorption and can lead to salt-sensitive hypertension, a major driver of kidney damage.

Bottom line

Common UMOD genetic variants are robustly associated with increased uromodulin production, which causally contributes to a 13-25% increased risk of chronic kidney disease and accelerated eGFR decline through mechanisms involving salt sensitivity and chronic inflammation.